Carestream Health Focuses on Developing Employees Wins Top Honor

Carestream Health has earned a Gold award for Excellence in Leadership Development from the Brandon Hall Group, a research, and analyst firm. The recognition lauds results and efforts from two high-potential development programs for emerging and senior leaders at Carestream.

Bluepoint, a facilitator of advanced leadership development concepts and coaching programs, collaborated with Carestream Health to create solutions that energized its leadership team.

“Carestream is serious about investing in our people. We know that empowered and energized employees fuel our company’s growth and vitality,” said Neil Bryant, Vice President of Leadership and Sales Development, Americas at Carestream. “We are grateful for our partnership with Bluepoint. Their expertise and collaboration were essential for our collective success.”

During the program, participants learned about their strengths and development opportunities available to them. The participants worked in groups and individually to examine and hone key leadership competencies and benefited from personalized executive coaching. Each program included assessments, custom leadership development workshops, and micro-eLearning programs.

As a result of those programs, Carestream has experienced renewed enthusiasm around leadership, innovation and collaboration. Participants continue their collaborative relationships and connect as business needs arise at Carestream.

“Our emerging and existing leaders have benefited greatly from this program by elevating their skills, ability, performance and enjoyment of leading through their own professional growth,” Mr. Bryant said. “Carestream benefits by having key employees who are more empowered and more engaged in making the company stronger.”

Award entries were evaluated by a panel of veteran, independent senior industry experts, Brandon Hall Group analysts and executives. The entries were judged based on need and design of the program, functionality, innovation and overall measurable benefits.
“Excellence Award winners distinguish themselves through their growing understanding that all the functions of Human Capital Management are integrated and must work together to move businesses forward,” said Brandon Hall Group Chief Operating Officer Rachel Cooke, leader of the HCM Excellence Awards program.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”